{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:07:42Z","timestamp":1788520062411,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deke Medical"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The objective of this preclinical study was to evaluate the feasibility and safety of transcatheter endocardial alginate hydrogel injection (TEAi) in a large animal model, utilizing the high-stiffness XDROP\u00ae alginate hydrogel in combination with the dedicated EndoWings\u00ae catheter-based system. All swine (<jats:italic>n<\/jats:italic>\u2009=\u20099) successfully underwent TEAi without complications. Acute results from a subset of animals (<jats:italic>n<\/jats:italic>\u2009=\u20095) demonstrated the ability of the catheter to access a wide range of endomyocardial areas and achieve consecutive circumferential hydrogel distribution patterns within the mid-left ventricular wall. Histological examinations at 6\u00a0months (<jats:italic>n<\/jats:italic>\u2009=\u20094) demonstrated that the XDROP\u00ae remained localized within the cardiac tissue. In addition, serial echocardiographic imaging showed that XDROP\u00ae had no adverse impacts on LV systolic and diastolic functions. In conclusion, this innovative combination technology has the potential to overcome the translational barriers related to alginate hydrogel delivery to the myocardium.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s12265-024-10497-8","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T16:02:06Z","timestamp":1708444926000},"page":"842-850","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Percutaneous Alginate Hydrogel Endomyocardial Injection with a Novel Dedicated Catheter Delivery System: An Animal Feasibility Study"],"prefix":"10.1007","volume":"17","author":[{"given":"Bo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun-jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W. J. C.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7076-1185","authenticated-orcid":false,"given":"Ling","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"10497_CR1","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","volume":"128","author":"VL Roger","year":"2021","unstructured":"Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res. 2021;128:1421\u201334.","journal-title":"Circ Res"},{"key":"10497_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jamacardio.2019.5323","volume":"5","author":"DJ Goldstein","year":"2020","unstructured":"Goldstein DJ, Naka Y, Horstmanshof D, et al. Association of clinical outcomes with left ventricular assist device use by bridge to transplant or destination therapy intent: the multicenter study of MagLev technology in patients undergoing mechanical circulatory support therapy with HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial. JAMA Cardiol. 2020;5:411\u20139.","journal-title":"JAMA Cardiol"},{"key":"10497_CR3","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.3390\/ijms23073482","volume":"23","author":"T H\u00e4neke","year":"2022","unstructured":"H\u00e4neke T, Sahara M. Progress in bioengineering strategies for heart regenerative medicine. Int J Mol Sci. 2022;23:3482.","journal-title":"Int J Mol Sci"},{"key":"10497_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fbioe.2020.00414","volume":"8","author":"G Cattelan","year":"2020","unstructured":"Cattelan G, Guerrero Gerbol\u00e9s A, Foresti R, et al. Alginate formulations: current developments in the race for hydrogel-based cardiac regeneration. Front Bioeng Biotechnol. 2020;8:414.","journal-title":"Front Bioeng Biotechnol"},{"key":"10497_CR5","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jacc.2009.06.010","volume":"54","author":"J Leor","year":"2009","unstructured":"Leor J, Tuvia S, Guetta V, et al. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol. 2009;54:1014\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"10497_CR6","doi-asserted-by":"publisher","first-page":"H1708","DOI":"10.1152\/ajpheart.00911.2004","volume":"288","author":"P Cabrales","year":"2005","unstructured":"Cabrales P, Tsai AG, Intaglietta M. Alginate plasma expander maintains perfusion and plasma viscosity during extreme hemodilution. Am J Physiol Heart Circ Physiol. 2005;288:H1708-1716.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10497_CR7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/CIRCINTERVENTIONS.114.001478","volume":"7","author":"N Frey","year":"2014","unstructured":"Frey N, Linke A, S\u00fcselbeck T, et al. Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: a first-in-man study. Circ Cardiovasc Interv. 2014;7:806\u201312.","journal-title":"Circ Cardiovasc Interv"},{"key":"10497_CR8","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.ijcard.2013.01.003","volume":"168","author":"LC Lee","year":"2013","unstructured":"Lee LC, Wall ST, Klepach D, et al. Algisyl-LVR\u2122 with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart. Int J Cardiol. 2013;168:2022\u20138.","journal-title":"Int J Cardiol"},{"key":"10497_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.actbio.2020.07.046","volume":"114","author":"DS Li","year":"2020","unstructured":"Li DS, Avazmohammadi R, Rodell CB, et al. How hydrogel inclusions modulate the local mechanical response in early and fully formed post-infarcted myocardium. Acta Biomater. 2020;114:296\u2013306.","journal-title":"Acta Biomater"},{"key":"10497_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.12989\/aba.2013.1.1.041","volume":"1","author":"J Kortsmit","year":"2014","unstructured":"Kortsmit J, Davies NH, Miller R, Zilla P, Franz T. Computational predictions of improved of wall mechanics and function of the infarcted left ventricle at early and late remodelling stages: comparison of layered and bulk hydrogel injectates. Adv Biomech Appl. 2014;1:41\u201355.","journal-title":"Adv Biomech Appl"},{"key":"10497_CR11","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.106.657270","volume":"114","author":"ST Wall","year":"2006","unstructured":"Wall ST, Walker JC, Healy KE, Ratcliffe MB, Guccione JM. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation. 2006;114:2627\u201335.","journal-title":"Circulation"},{"key":"10497_CR12","doi-asserted-by":"publisher","first-page":"e004058","DOI":"10.1161\/CIRCINTERVENTIONS.116.004058","volume":"9","author":"CB Rodell","year":"2016","unstructured":"Rodell CB, Lee ME, Wang H, et al. Injectable shear-thinning hydrogels for minimally invasive delivery to infarcted myocardium to limit left ventricular remodeling. Circ Cardiovasc Interv. 2016;9:e004058.","journal-title":"Circ Cardiovasc Interv"},{"key":"10497_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.actbio.2020.04.033","volume":"111","author":"KL Sack","year":"2020","unstructured":"Sack KL, Aliotta E, Choy JS, et al. Intra-myocardial alginate hydrogel injection acts as a left ventricular mid-wall constraint in swine. Acta Biomater. 2020;111:170\u201380.","journal-title":"Acta Biomater"},{"key":"10497_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.carrev.2020.06.031","volume":"22","author":"AN Raval","year":"2021","unstructured":"Raval AN, Pepine CJ. Clinical safety profile of transendocardial catheter injection systems: a plea for uniform reporting. Cardiovasc Revasc Med. 2021;22:100\u20138.","journal-title":"Cardiovasc Revasc Med"},{"key":"10497_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.xjon.2022.04.043","volume":"10","author":"T Shazly","year":"2022","unstructured":"Shazly T, Smith A, Uline MJ, Spinale FG. Therapeutic payload delivery to the myocardium: Evolving strategies and obstacles. JTCVS Open. 2022;10:185\u201394.","journal-title":"JTCVS Open"},{"key":"10497_CR16","doi-asserted-by":"publisher","first-page":"e2001116","DOI":"10.1002\/adhm.202001116","volume":"9","author":"G Parada","year":"2020","unstructured":"Parada G, Yu Y, Riley W, et al. Ultrathin and robust hydrogel coatings on cardiovascular medical devices to mitigate thromboembolic and infectious complications. Adv Healthc Mater. 2020;9:e2001116.","journal-title":"Adv Healthc Mater"},{"key":"10497_CR17","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1177\/0885328218805878","volume":"33","author":"EB Dolan","year":"2018","unstructured":"Dolan EB, Kovarova L, O\u2019Neill H, et al. Advanced material catheter (AMCath), a minimally invasive endocardial catheter for the delivery of fast-gelling covalently cross-linked hyaluronic acid hydrogels. J Biomater Appl. 2018;33:681\u201392.","journal-title":"J Biomater Appl"},{"key":"10497_CR18","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1002\/jbm.b.33802","volume":"105","author":"CJ Curley","year":"2017","unstructured":"Curley CJ, Dolan EB, Cavanagh B, O\u2019Sullivan J, Duffy GP, Murphy BP. An in vitro investigation to assess procedure parameters for injecting therapeutic hydrogels into the myocardium. J Biomed Mater Res B Appl Biomater. 2017;105:2618\u201329.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10497_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3109\/11038128.2011.553687","volume":"19","author":"T Nilsen","year":"2012","unstructured":"Nilsen T, Hermann M, Eriksen CS, Dagfinrud H, Mowinckel P, Kjeken I. Grip force and pinch grip in an adult population: reference values and factors associated with grip force. Scandinavian Journal of Occupational Therapy. 2012;19:288\u201396.","journal-title":"Scandinavian Journal of Occupational Therapy"},{"key":"10497_CR20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1161\/CIRCULATIONAHA.107.727420","volume":"117","author":"N Landa","year":"2008","unstructured":"Landa N, Miller L, Feinberg MS, et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 2008;117:1388\u201396.","journal-title":"Circulation"},{"key":"10497_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jacc.2016.05.053","volume":"68","author":"SV Rao","year":"2016","unstructured":"Rao SV, Zeymer U, Douglas PS, et al. Bioabsorbable intracoronary matrix for prevention of ventricular remodeling after myocardial infarction. J Am Coll Cardiol. 2016;68:715\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"10497_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jchf.2013.02.006","volume":"1","author":"HN Sabbah","year":"2013","unstructured":"Sabbah HN, Wang M, Gupta RC, et al. Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure. JACC Heart Fail. 2013;1:252\u20138.","journal-title":"JACC Heart Fail"},{"key":"10497_CR23","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1093\/eurheartj\/ehv259","volume":"36","author":"SD Anker","year":"2015","unstructured":"Anker SD, Coats AJS, Cristian G, et al. A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial). Eur Heart J. 2015;36:2297\u2013309.","journal-title":"Eur Heart J"},{"key":"10497_CR24","doi-asserted-by":"publisher","unstructured":"Bartunek J, Terzic A, Davison BA, et al. Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomes. ESC Heart Fail. 2020. https:\/\/doi.org\/10.1002\/ehf2.13031","DOI":"10.1002\/ehf2.13031"},{"key":"10497_CR25","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1161\/01.CIR.0000074776.88681.F5","volume":"107","author":"RA Omary","year":"2003","unstructured":"Omary RA, Green JD, Schirf BE, Li Y, Finn JP, Li D. Real-time magnetic resonance imaging-guided coronary catheterization in swine. Circulation. 2003;107:2656\u20139.","journal-title":"Circulation"},{"key":"10497_CR26","doi-asserted-by":"crossref","unstructured":"Smits PC, van Geuns R-JM, Poldermans D, et al. Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure. J Am Coll Cardiol. 2003;42:2063\u20132069","DOI":"10.1016\/j.jacc.2003.06.017"},{"key":"10497_CR27","first-page":"480","volume":"1","author":"H Leonhardt","year":"2006","unstructured":"Leonhardt H, Spencer R. SR200 MyoCath percutaneous microimplant delivery system. EuroIntervention. 2006;1:480\u20131.","journal-title":"EuroIntervention"},{"key":"10497_CR28","doi-asserted-by":"crossref","unstructured":"Traverse JH, Henry TD, Dib N, et al. First-in-man study of a cardiac extracellular matrix hydrogel in early and late myocardial infarction patients. JACC: Basic to Translational Science. 2019;4:659\u2013669","DOI":"10.1016\/j.jacbts.2019.07.012"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-024-10497-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-024-10497-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-024-10497-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T15:34:47Z","timestamp":1725377687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-024-10497-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10497"],"URL":"https:\/\/doi.org\/10.1007\/s12265-024-10497-8","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LT and BW report grants from Deke MedTech. PS reports consultancy for SMT, Philips, Xeltis, Merillife, and Novartis. The remaining authors declare no competing interests.No human studies were carried out by the authors for this article.All institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}]}}